In keeping with what has been observed in PDAC and CRC, a downregulation in the expression of the main NCRs, i.e., NKp30 and NKp46, together with NKG2D and DNAM1 (see below), has been observed in circulating NK cells from GC patients at different stages. This evidence concerns the gene CD226 and colorectal carcinoma.